144 related articles for article (PubMed ID: 10191675)
21. Role of platelets in restenosis after percutaneous coronary revascularization.
Le Breton H; Plow EF; Topol EJ
J Am Coll Cardiol; 1996 Dec; 28(7):1643-51. PubMed ID: 8962547
[TBL] [Abstract][Full Text] [Related]
22. Antiplatelet and anticoagulant therapy in patients undergoing percutaneous transluminal coronary angioplasty.
Barry WL; Sarembock IJ
Cardiol Clin; 1994 Aug; 12(3):517-35. PubMed ID: 7805084
[TBL] [Abstract][Full Text] [Related]
23. Lotrafiban: an oral platelet glycoprotein IIb/IIIa blocker.
Liu F; Craft RM; Morris SA; Carroll RC
Expert Opin Investig Drugs; 2000 Nov; 9(11):2673-87. PubMed ID: 11060829
[TBL] [Abstract][Full Text] [Related]
24. Wall passivation for unstable angina.
Lettino M; Dailey-Sterling F; Badimon L; Chesebro JH; Badimon JJ
Semin Interv Cardiol; 1996 Mar; 1(1):60-6. PubMed ID: 9552495
[TBL] [Abstract][Full Text] [Related]
25. Anti-platelet therapy: glycoprotein IIb-IIIa antagonists.
Schneider DJ
Br J Clin Pharmacol; 2011 Oct; 72(4):672-82. PubMed ID: 21906121
[TBL] [Abstract][Full Text] [Related]
26. [The efficacy of platelet IIb/IIIa receptor blockers in acute coronary syndromes].
Sitges M; Bosch X; Sanz G
Rev Esp Cardiol; 2000 Mar; 53(3):422-39. PubMed ID: 10712972
[TBL] [Abstract][Full Text] [Related]
27. Restenosis, the Achilles' heel of coronary angioplasty.
Wurdeman RL; Hilleman DE; Mooss AN
Pharmacotherapy; 1998; 18(5):1024-40. PubMed ID: 9758313
[TBL] [Abstract][Full Text] [Related]
28. The problem of persistent platelet activation in acute coronary syndromes and following percutaneous coronary intervention.
Braunwald E; Angiolillo D; Bates E; Berger PB; Bhatt D; Cannon CP; Furman MI; Gurbel P; Michelson AD; Peterson E; Wiviott S
Clin Cardiol; 2008 Mar; 31(3 Suppl 1):I17-20. PubMed ID: 18481817
[TBL] [Abstract][Full Text] [Related]
29. The clinical impact of platelet glycoprotein IIb/IIIa receptor blockade in cardiovascular medicine.
Mak KH; Tan AT; Chan C; Koh TH; Topol EJ
Jpn Circ J; 1998 Apr; 62(4):233-43. PubMed ID: 9583455
[TBL] [Abstract][Full Text] [Related]
30. Contemporary antiplatelet therapy in patients undergoing percutaneous coronary intervention.
Bhatty S; Ali A; Shetty R; Sumption KF; Cowley MJ; Jovin IS
Expert Rev Cardiovasc Ther; 2014 Apr; 12(4):463-74. PubMed ID: 24650313
[TBL] [Abstract][Full Text] [Related]
31. Antiplatelet therapies: platelet GPIIb/IIIa antagonists and beyond.
Mousa SA
Curr Pharm Des; 2003; 9(28):2317-22. PubMed ID: 14529393
[TBL] [Abstract][Full Text] [Related]
32. Intravenous glycoprotein IIb/IIIa antagonists: their benefits, problems and future developments.
Curtin R
Curr Pharm Des; 2004; 10(14):1577-85. PubMed ID: 15134556
[TBL] [Abstract][Full Text] [Related]
33. Platelet glycoprotein IIb/IIIa receptor antagonists in coronary artery disease.
Lefkovits J; Topol EJ
Eur Heart J; 1996 Jan; 17(1):9-18. PubMed ID: 8682137
[No Abstract] [Full Text] [Related]
34. Role of platelet inhibition in microvascular surgery.
Cho EH; Ligh C; Hodulik KL; Hollenbeck ST
J Reconstr Microsurg; 2014 Nov; 30(9):589-98. PubMed ID: 25089565
[TBL] [Abstract][Full Text] [Related]
35. [Management of high thrombus burden in primary PCI].
Mangin L; Lotfi M; Puie P; Yayehd K; Ispas A; Belle L
Ann Cardiol Angeiol (Paris); 2017 Dec; 66(6):380-384. PubMed ID: 29096903
[TBL] [Abstract][Full Text] [Related]
36. Platelet glycoprotein IIb/IIIa antagonists: pharmacology and clinical developments.
Kam PC; Egan MK
Anesthesiology; 2002 May; 96(5):1237-49. PubMed ID: 11981166
[No Abstract] [Full Text] [Related]
37. Arteriosclerosis and the promise of GPIIb/IIIa inhibitors in stroke.
Saposnik G; Caplan LR
Arq Neuropsiquiatr; 2000 Mar; 58(1):1-10. PubMed ID: 10770859
[TBL] [Abstract][Full Text] [Related]
38. What Role for Glycoprotein IIb/IIIa Inhibition in Contemporary Coronary Intervention?
Lincoff AM
JACC Cardiovasc Interv; 2015 Oct; 8(12):1583-5. PubMed ID: 26493251
[No Abstract] [Full Text] [Related]
39. Intracoronary drugs during percutaneous interventions: the highway has different lanes!
Cortese B; Biondi-Zoccai G
J Cardiovasc Med (Hagerstown); 2011 Apr; 12(4):303-4. PubMed ID: 20733509
[No Abstract] [Full Text] [Related]
40. Platelet Glycoprotein IIb/IIIa Integrin Blockade in Coronary Artery Disease: Current State of the Art.
Tan HC; Harrington RA; Tcheng JE
J Thromb Thrombolysis; 1997; 4(3/4):431-439. PubMed ID: 10639648
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
